These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31154425)

  • 1. Clinical determinants of plasma cardiac biomarkers in patients with stable chest pain.
    Bing R; Henderson J; Hunter A; Williams MC; Moss AJ; Shah ASV; McAllister DA; Dweck MR; Newby DE; Mills NL; Adamson PD
    Heart; 2019 Nov; 105(22):1748-1754. PubMed ID: 31154425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris.
    Adamson PD; Hunter A; Madsen DM; Shah ASV; McAllister DA; Pawade TA; Williams MC; Berry C; Boon NA; Flather M; Forbes J; McLean S; Roditi G; Timmis AD; van Beek EJR; Dweck MR; Mickley H; Mills NL; Newby DE
    Circ Cardiovasc Qual Outcomes; 2018 Feb; 11(2):e004227. PubMed ID: 29444926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of B-type natriuretic peptide with coronary plaque subtypes detected by coronary computed tomography angiography in patients with stable chest pain.
    Yang Y; Li C; Zhao L
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1599-1606. PubMed ID: 28396960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD: Insights From the PROMISE Trial.
    Januzzi JL; Suchindran S; Coles A; Ferencik M; Patel MR; Hoffmann U; Ginsburg GS; Douglas PS;
    JACC Cardiovasc Imaging; 2019 Jun; 12(6):1047-1055. PubMed ID: 29550314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental value of B-type natriuretic peptide for detection and risk reclassification of obstructive coronary artery disease on computed tomography angiography.
    Kawabe M; Sato A; Hoshi T; Endo M; Yoshida I; Aonuma K
    J Cardiol; 2017 Apr; 69(4):671-677. PubMed ID: 27443597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
    Madsen DM; Diederichsen ACP; Hosbond SE; Gerke O; Mickley H
    Atherosclerosis; 2017 Mar; 258():131-137. PubMed ID: 28031149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction.
    Henzler T; Roeger S; Meyer M; Schoepf UJ; Nance JW; Haghi D; Kaminski WE; Neumaier M; Schoenberg SO; Fink C
    Eur Respir J; 2012 Apr; 39(4):919-26. PubMed ID: 21965223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk classification of highly sensitive troponin I predict presence of vulnerable plaque assessed by dual source coronary computed tomography angiography.
    Liu T; Wang G; Li P; Dai X
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1831-1839. PubMed ID: 28528430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia.
    Puelacher C; Wagener M; Honegger U; Assadian M; Schaerli N; Mueller D; Strebel I; Twerenbold R; Boeddinghaus J; Nestelberger T; Wildi K; Sabti Z; Sazgary L; Badertscher P; du Fay de Lavallaz J; Marbot S; Kaiser C; Wild D; Zellweger MJ; Reichlin T; Mueller C
    Clin Biochem; 2018 Feb; 52():33-40. PubMed ID: 29107010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50.
    Berg DD; Freedman BL; Bonaca MP; Jarolim P; Scirica BM; Goodrich EL; Sabatine MS; Morrow DA
    J Am Heart Assoc; 2021 May; 10(9):e018673. PubMed ID: 33884889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary low-attenuation plaque and high-sensitivity cardiac troponin.
    Meah MN; Wereski R; Bularga A; van Beek EJR; Dweck MR; Mills NL; Newby DE; Dey D; Williams MC; Lee KK
    Heart; 2023 Apr; 109(9):702-709. PubMed ID: 36631142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
    Palazzuoli A; Caputo M; Fineschi M; Navarri R; Calabrò A; Cameli M; Campagna MS; Franci B; Pierli C; Nuti R; Maisel A
    Eur J Prev Cardiol; 2012 Jun; 19(3):366-73. PubMed ID: 21464097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
    Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
    Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study.
    Tonkin AM; Blankenberg S; Kirby A; Zeller T; Colquhoun DM; Funke-Kaiser A; Hague W; Hunt D; Keech AC; Nestel P; Stewart R; Sullivan DR; Thompson PL; West M; White HD; Simes J;
    Int J Cardiol; 2015 Dec; 201():499-507. PubMed ID: 26318511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease.
    Sahinarslan A; Cengel A; Okyay K; Yazici HU; Elbey S; Cemri M; Ozdemir M; Timurkaynak T
    Coron Artery Dis; 2005 Jun; 16(4):225-9. PubMed ID: 15915074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troponin T and N-terminal pro B-Type natriuretic peptide and presence of coronary artery disease.
    Mouridsen MR; Sajadieh A; Carlsen CM; Mattsson N; Heitmann M; Nielsen OW
    Scand J Clin Lab Invest; 2015 May; 75(3):204-12. PubMed ID: 25629204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.